XML 17 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:    
Loss for the period $ (2,815,762) $ (3,201,337)
Adjustments to reconcile income (loss) for the period to net cash used in operating activities:    
Depreciation 27,980 18,359
Stock-based compensation 34,297 12,147
Incremental fair market value adjustments of modified warrants issued to placement agent 211,077
Change in the fair value of Warrants with down-round protection (64,212) (91,309)
Linkage difference on principal of loans from stockholders (639) (1,872)
Loss on partial extinguishment of Series A Preferred Stock and Series A Warrants 1,270,971
Changes in assets and liabilities:    
Increase in accounts receivable (51,053) (3,149)
Decrease (increase) in inventory 130,203 (51,036)
Decrease (increase) in other current assets 147,697 (17,474)
(Decrease) increase in accounts payable (638,908) 145,388
Increase in other current liabilities 132,153 83,030
Net cash used in operating activities (2,887,167) (1,836,282)
Cash flows from investing activities:    
Increase in funds in respect of employee rights upon retirement (24,279)
Purchase of property and equipment (46,397) (18,892)
Net cash used in investing activities (46,397) (43,171)
Cash flows from financing activities    
Cash dividend on Series A Preferred Stock (4,753) (47,036)
Proceeds allocated to Series C Preferred Stock, net of cash issuance expenses 2,508,321
Proceeds allocated to Series C Warrants, net of cash issuance expenses 1,242,158
Repayment of loan from stockholders (439,939)
Net cash provided by (used in) financing activities 3,745,726 (486,975)
Effect of exchange rate changes on cash and cash equivalents (15,329) 54,941
Increase (decrease) in cash and cash equivalents 796,833 (2,311,487)
Cash and cash equivalents at beginning of the period 608,701 5,827,560
Cash and cash equivalents at end of the period $ 1,405,534 $ 3,516,073